Drug intelligence / Profile preview

tolfenamic acid

Development stage
Phase 2
Lead developer
Medica
Modality
Small Molecules
Administration
Oral
01

Overview

Tolfenamic acid is a non-steroidal anti-inflammatory drug (NSAID) of the fenamate class (anthranilic acid derivatives), primarily used for its analgesic and anti-inflammatory properties. It is indicated for the treatment of migraine headaches and other conditions associated with pain and inflammation. The drug acts mainly by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to reduced synthesis of prostaglandins, which are mediators of inflammation, pain, and fever. Tolfenamic acid also inhibits leukotriene synthesis and has been shown to partially inhibit leukotriene B4 chemotaxis in human polymorphonuclear leukocytes. Additionally, research suggests it may have anti-cancer activity by altering gene expression related to apoptosis, growth arrest, angiogenesis, and metastasis[1][2][3][6][8]. It was originally discovered by Medica Pharmaceutical Company in Finland[3].

Brand names
Clotam Rapid
Other names
Acide tolfenamiqueácido tolfenámicoAcidum tolfenamicum
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on tolfenamic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tolfenamic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call